olvanil   Click here for help

GtoPdb Ligand ID: 2488

Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 2
Rotatable bonds 19
Topological polar surface area 58.56
Molecular weight 417.32
XLogP 8.93
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCCCCCC=CCCCCCCCC(=O)NCc1ccc(c(c1)OC)O
Isomeric SMILES CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(c(c1)OC)O
InChI InChI=1S/C26H43NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-26(29)27-22-23-19-20-24(28)25(21-23)30-2/h10-11,19-21,28H,3-9,12-18,22H2,1-2H3,(H,27,29)/b11-10-
InChI Key OPZKBPQVWDSATI-KHPPLWFESA-N
References
1. Chu ZL, Carroll C, Chen R, Alfonso J, Gutierrez V, He H, Lucman A, Xing C, Sebring K, Zhou J et al.. (2010)
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.
Mol Endocrinol, 24 (1): 161-70. [PMID:19901198]
2. Correll CC, Phelps PT, Anthes JC, Umland S, Greenfeder S. (2004)
Cloning and pharmacological characterization of mouse TRPV1.
Neurosci Lett, 370 (1): 55-60. [PMID:15489017]
3. Jerman JC, Brough SJ, Prinjha R, Harries MH, Davis JB, Smart D. (2000)
Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology.
Br J Pharmacol, 130 (4): 916-22. [PMID:10864900]
4. Smart D, Jerman JC, Gunthorpe MJ, Brough SJ, Ranson J, Cairns W, Hayes PD, Randall AD, Davis JB. (2001)
Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology.
Eur J Pharmacol, 417 (1-2): 51-8. [PMID:11301059]